U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148193) titled 'Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)' on Aug. 22.
Brief Summary: The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (>= 5 years post-diagnosis, with or without active disease) in Germany. The mixed-methods research design includes a multicenter observational study with a cross-sectional questionnaire survey involving 1,600 participants (paper, online), qualitative interviews with up to 60 participants, and longitudinal analyses combining data from existing sarcoma registrie...